|
C3ORF37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.704020E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.917530E-03 |
| Normal-vs-Stage2 |
5.569400E-01 |
| Normal-vs-Stage3 |
8.402500E-02 |
| Normal-vs-Stage4 |
3.366400E-02 |
| Stage1-vs-Stage2 |
2.367700E-02 |
| Stage1-vs-Stage3 |
9.464000E-02 |
| Stage1-vs-Stage4 |
7.016600E-01 |
| Stage2-vs-Stage3 |
2.292200E-01 |
| Stage2-vs-Stage4 |
1.066180E-01 |
| Stage3-vs-Stage4 |
4.246200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.999500E-03 |
| Normal-vs-AfricanAmerican |
1.580020E-01 |
| Normal-vs-Asian |
1.835520E-03 |
| Caucasian-vs-AfricanAmerican |
7.224000E-01 |
| Caucasian-vs-Asian |
2.248200E-01 |
| AfricanAmerican-vs-Asian |
2.514800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.046000E-02 |
| Normal-vs-Female |
1.279620E-02 |
| Male-vs-Female |
3.721200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.205900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.615700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.800000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.383200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.151700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.400200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.768000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.985410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.104200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.583600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.842000E-01 |
| Classical-VS-Follicular |
4.70734562441066E-14 |
| Classical-VS-Other |
1.720160E-01 |
| Classical-VS-Normal |
4.771000E-04 |
| Tall-VS-Follicular |
5.97270000000094E-05 |
| Tall-VS-Other |
3.149800E-01 |
| Tall-VS-Normal |
2.186500E-02 |
| Follicular-VS-Other |
2.734800E-01 |
| Follicular-VS-Normal |
2.382200E-01 |
| Other-VS-Normal |
6.672800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.208100E-02 |
| Normal-vs-N1 |
2.344200E-01 |
| N0-vs-N1 |
8.707600E-01 |
|
|
